Showing results (171-180 of 287) with videos related to

Sort By:
Pageof 29
The American Journal of Pathology|February 1, 1993
Phagocytosis of latex beads is defective in cultured human retinal pigment epithelial cells with persistent rubella virus infectionL L Williams, H M Lew, B T Shannon, et al.
Clinical and Experimental Immunology|March 1, 1979
Progressive rubella panencephalitis: immunovirological studies and results of isoprinosine therapyJ S Wolinsky, P C Dau, E Buimovici-Klein, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
Regional gray matter atrophy in relapsing remitting multiple sclerosis: baseline analysis of multi-center dataSushmita Datta, Terrell D Staewen, Stacy S Cofield, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesionsColm Elliott, Jerry S Wolinsky, Stephen L Hauser, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 20, 2016
Limbic Pathway Correlates of Cognitive Impairment in Multiple SclerosisZafer Keser, Khader M Hasan, Benson Mwangi, et al.
European Journal of Neurology|March 16, 2021
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trialsGavin Giovannoni, Ludwig Kappos, Jerome de Seze, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 21, 2005
Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study groupMassimo Filippi, Andrea Falini, Douglas L Arnold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trialsFilippo Martinelli Boneschi, Marco Rovaris, Kenneth P Johnson, et al.
Annals of Neurology|April 1, 1995
Decreased CD3-mediated interferon-gamma production in relapsing-remitting multiple sclerosisS A Brod, M Khan, J Bright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2007
Long-term follow-up of patients treated with glatiramer acetate: a multicentre, multinational extension of the European/Canadian double-blind, placebo-controlled, MRI-monitored trialM Rovaris, G Comi, M A Rocca, et al.
Pageof 29